$AB

Stonehill Charles G.T. sold $186K of AB

Stonehill Charles G.T. sold 5,000 shares of ALLIANCEBERNSTEIN HOLDING L.P. (AB) at $37.17 ($0.19M total) on 2026-08-04.

Original reporting
SEC EDGAR · Stonehill Charles G.T.
Published Aug 6, 2026, 9:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AB
Neutral
medium confidence
Mentioned
$AB
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ABNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale of 5,000 shares at $37.17, totaling $185,850, reported via EDGAR on 2026-08-06.

02

Market read

Traders may monitor insider activity for sentiment, but this filing does not introduce new fundamentals or catalysts.

03

What to watch

The article notes no pre-arranged 10b5-1 plan, but it does not provide context on taxes, estate planning, or whether other holdings were adjusted.

Relevance 4/10Novelty 3/10Timing: filed after-hours on 2026-08-06, reflecting a prior 2026-08-04 sale

Background

The article is a SEC Form 4 insider transaction disclosure for AllianceBernstein Holding L.P. (AB).

Company-level read

Ticker impact

$ABNeutralMedium confidence
Context

AllianceBernstein Holding L.P. disclosed an insider Form 4 showing director Charles G.T. Stonehill sold 5,000 shares at $37.17 on 2026-08-04.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than based on new fundamentals.

Evidence & confidence

The filing is a disclosed insider transaction (size $185,850) without accompanying guidance, earnings, or operational/regulatory developments.

Market effects

No clear sector read-through; this is company-specific insider selling with no stated business change.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification or liquidity needs and does not necessarily indicate bearish expectations, especially for directors with planned personal cash-flow needs.

Key entities

  • AllianceBernstein Holding L.P.

    Subject of the Form 4 insider transaction disclosure.

  • Stonehill Charles G.T.

    Director who sold 5,000 shares on 2026-08-04.

Related articles

$ABMed

AllianceBernstein Holding L.P. Q2 2026 Earnings Call Summary

Strategic Execution and Platform Scaling Achieved record AUM of $905 billion, driven by a return to positive organic growth and the strongest gross sales quarter in five years. Reached the $90 billion to $100 billion private markets AUM target more than a year ahead of schedule, validating a multi-year investment strategy in corporate lending and real estate debt.

$ABMed

AllianceBernstein Holding LP (AB) Q2 2026 Earnings Call Highlights: Record AUM

AllianceBernstein (AB) discussed Q2 2026 earnings call topics, including expectations for the Equitable Corebridge merger to add about $100B of AUM over a couple of years, with combined general account assets around $350B and separate around $200B. Management cited resilient private wealth adviser productivity, reduced expense guidance by $5-10M, and demand shifts in U.S. taxable fixed income.

$ABMedAI 8/10

Advanced Bionics Receives FDA Approval for Expanded Cochlear Implant Candidacy Criteria in SSD and AHL

Advanced Bionics, a Sonova brand, said the US FDA approved expanded indications for its cochlear implant systems for single-sided deafness (SSD) and asymmetric hearing loss (AHL). The criteria broaden adult and pediatric eligibility, with company-cited research estimating 271,000 to 345,000 US adults with SSD and only 2.1% using CIs among eligible patients.

$ABMed

ALLIANCEBERNSTEIN HOLDING L.P. (AB): Results of Operations and Financial Condition

ALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.01 2 a2q26earningsrelease.htm EX-99.01 2Q26 RELEASE Document Ioanis Jorgali, Investors 629.213.6139 ioanis.jorgali@alliancebernstein.com Carly Symington, Media 629.213.5568 carly.symington@alliancebernstein.com ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES SECOND QUARTER RESULTS